CompletedNot Applicable

A Randomized Controlled Trial of an Advanced Care Planning Video Decision Support Tool for Patients With End-Stage Liver Disease

United States50 participantsStarted 2018-09-28

Plain-language summary

The goal of this pilot randomized trial is to assess the feasibility and preliminary efficacy of an advanced care planning (ACP) video decision support tool for improving patients' knowledge regarding their goals of care options and end of life (EOL) decision-making in patients with end-stage liver disease (ESLD).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. ≥ 18 years of age with an established diagnosis of end-stage liver disease
✓. Patient must have either 1) primary hepatologist at the MGH Liver Center or an MGH-affiliated primary care physician, or 2) a previous inpatient admission at MGH
✓. Deemed ineligible for liver transplantation as determined by the primary hepatologist
✓. Ability to communicate in English and provide informed consent
✓. A score ≥ 7 on the Short Portable Mental Status Questionnaire

Exclusion criteria

✕. Severe hepatic encephalopathy which the primary hepatologist believes prohibits informed consent or participation in the study
✕. Significant uncontrolled psychiatric disorders (psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (dementia, cognitive impairment), which the primary hepatologist believes prohibits informed consent or participation in the study
✕. Prior history of liver transplantation
✕. Patient has been referred to or enrolled in hospice care
✕. Patients who have been referred to palliative care

What they're measuring

Number of Eligible Participants Enrolled in the Study

Timeframe: By 12 months

Trial details

NCT IDNCT03557086

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-03-03

Results submitted2021-08-31

View on ClinicalTrials.gov More End Stage Liver Disease trials